Genpharm facilitates expedited entry into the Middle East and North Africa (MENA) region for pharmaceutical companies specializing in Rare Diseases and specialty products. The company, established in 2012, is a financially stable private entity and a prominent player in the field of Rare Diseases, with exclusive expertise in Gene Therapy. Genpharm is headquartered in the Dubai Science Park (DSP), U.A.E., and maintains offices in Boston, at the core of the Biotech hub, and in Ireland. It boasts a team of highly qualified and experienced Medical Science Liaisons (MSLs) and Key Account Managers (KAMs), providing comprehensive regulatory, medical, pharmacovigilance (PV), and logistical assistance.